Comparable Transaction Analysis
Valuation Methods — Lesson 6 of 10
The market approach is the most instinctive valuation technique: an asset is worth what someone will pay for it. In real estate, this principle works reliably because thousands of comparable properties trade every month. In public equities, market prices are observable in real time. For intangible assets, the market approach is appealing in theory but constrained in practice — because intangible assets are, by definition, unique.
No two patent portfolios cover the same claims. No two customer databases contain the same records. No two brands carry the same associations. This uniqueness makes direct comparisons difficult. But it does not make the market approach irrelevant. When comparable data exists — from licensing agreements, IP auctions, technology transfer deals, or domain name sales — the market approach can provide the strongest evidence of value precisely because it reflects what real buyers actually pay.
This lesson explains where to find comparable data, how to make adjustments for differences, and when the market approach provides reliable evidence versus when it should serve only as a cross-check.
The market approach values an intangible asset by reference to prices paid for comparable assets in arm's-length transactions. Its strength is objectivity — it reflects actual market behaviour. Its limitation is comparability — intangible assets are inherently unique, so adjustments are always required. The approach works best for assets with active licensing or trading markets.
Where to Find Comparable Data
The availability of comparable transaction data varies enormously by asset type.
Comparable Data Sources by Asset Type
| Asset Type | Data Source | Data Quality | Coverage |
|---|---|---|---|
| Patents / technology | RoyaltyStat, ktMINE, Innography | High | Licensing agreements across industries |
| Pharmaceutical IP | PharmaDeals, Evaluate Pharma | High | Drug licensing and co-development deals |
| Domain names | NameBio, DN Journal, Sedo | High | Millions of domain sale records |
| Content / media rights | MUSO, PRS for Music | Moderate | Licensing rates for content categories |
| Brands / trademarks | Brand Finance, Interbrand | Moderate | Publicly ranked brands only |
| Customer databases | Limited | Low | Rarely traded independently |
| Software | Limited | Low | Typically embedded in M&A, not standalone |
Types of Market Evidence
The market approach uses two types of evidence, each suited to different contexts.
1. Comparable Transactions (Direct Sales)
This involves identifying transactions where similar intangible assets were sold or transferred between unrelated parties, and deriving value from the transaction price.
Application: Domain name valuation, patent portfolio sales, content library acquisitions.
Strength: Direct evidence of what buyers pay. No model risk.
Limitation: Transactions must be truly comparable. A $1 million domain name sale for "insurance.com" is not a comparable for "nicheproduct.co.uk" — the traffic, revenue, and strategic value are incomparable.
2. Comparable Licensing Agreements (Royalty Rates)
This involves identifying arm's-length licensing agreements for similar assets and deriving royalty rates that can feed into a Relief from Royalty analysis.
Application: Patent licensing, brand licensing, technology licensing.
Strength: Large databases exist with thousands of agreements. Statistical analysis is possible.
Limitation: Licensing terms vary significantly. A 5% royalty rate in one agreement may include technical support, training, and exclusivity. A 5% rate in another may cover bare IP rights only.
When using the market approach to support an RFR analysis, the royalty rate derived from comparable agreements becomes the market-based input. The RFR calculation (revenue x royalty rate x tax adjustment, discounted to present value) then converts that rate into a value. The two methods work in tandem — the market approach provides the rate, the income approach provides the framework.
Making Adjustments
No two transactions are perfectly comparable. Adjustments are always necessary, and the quality of the valuation depends on how rigorously they are applied.
The Adjustment Framework
1. Identify the key comparability factors
Determine which characteristics most affect value: industry, asset maturity, market position, exclusivity, geographic scope, revenue base, remaining useful life, and competitive landscape.
2. Assess each comparable against the subject
For each comparable transaction, document how the transacted asset differs from the subject asset on each key factor. Score each difference as minor (requires no adjustment), moderate (requires adjustment of 10-20%), or major (requires adjustment of 20%+ or disqualifies the comparable).
3. Apply quantitative adjustments
Adjust the comparable transaction price or royalty rate for each material difference. Document the basis for each adjustment.
4. Triangulate across multiple comparables
Use at least 3-5 comparables. Calculate the median and interquartile range. Weight more comparable transactions more heavily. The adjusted range provides the market-derived indication of value.
Common Adjustment Factors
Adjustment Matrix for Comparable Transactions
| Factor | Direction | Typical Magnitude | Rationale |
|---|---|---|---|
| Market position (stronger vs. weaker) | Upward for stronger | 10-30% | Dominant brands/technology command premium |
| Geographic scope (broader vs. narrower) | Upward for broader | 5-20% | Wider territory = larger addressable market |
| Exclusivity (exclusive vs. non-exclusive) | Upward for exclusive | 15-40% | Exclusivity has significant option value |
| Remaining useful life (longer vs. shorter) | Upward for longer | Pro rata | Directly proportional to expected benefit period |
| Revenue base (larger vs. smaller) | Context-dependent | 5-15% | Larger revenue base may indicate more established asset |
| Transaction date (older vs. recent) | Adjust to current | Varies | Market conditions change; older data is less relevant |
A valuer is assessing a UK-registered pharmaceutical patent using comparable licensing deals. The three most relevant comparable deals show royalty rates of 6%, 7.5%, and 8% of net sales. However, two of the comparables involve US-only licences, while the subject patent has global coverage. The valuer applies a 15% upward adjustment to the US-only comparables to reflect the broader geographic scope, producing an adjusted range of 6.9% to 8%. Combined with the third comparable (already global at 7.5%), the indicated royalty rate range is 6.9% to 8.0%, with a median of 7.5%.
When the Market Approach Works Best
The market approach is most reliable when five conditions are met.
| Condition | Why It Matters |
|---|---|
| Active market for similar assets | Sufficient transaction volume to establish patterns |
| Arms-length transactions | Related-party transactions distort prices |
| Recent data (within 3-5 years) | Market conditions evolve; stale data is unreliable |
| Reasonably comparable assets | Adjustments should be moderate, not transformative |
| Transparent transaction terms | Price must be isolable from bundled deal components |
When all five conditions are met — as in pharmaceutical licensing, domain name sales, and certain technology categories — the market approach may provide stronger evidence than the income approach.
When fewer than three conditions are met, the market approach should serve as a secondary cross-check rather than the primary method.
The Hybrid Approach
In practice, the market approach rarely stands alone for intangible assets. Instead, it provides market-derived inputs (royalty rates, multiples, transaction benchmarks) that feed into income approach calculations. A Relief from Royalty analysis using market-derived royalty rates combines the strengths of both approaches — the market provides the rate, and the income approach provides the present-value framework. This hybrid is considered best practice by the International Valuation Standards.
Limitations and Challenges
Uniqueness of intangible assets. Every brand is different. Every patent covers different claims. Every customer base has a different composition. The adjustments required to bridge from a comparable to the subject can be so large that the comparable provides little meaningful evidence.
Bundled transactions. Many intangible asset transactions are embedded in larger M&A deals. Extracting the price paid for a specific intangible from a $500 million acquisition requires a purchase price allocation — which itself relies on the income approach. This circularity limits the independence of market data derived from M&A.
Selection bias. Licensing databases contain agreements that parties chose to file or disclose. Agreements with unusual terms — very high or very low rates — may be over-represented. Professional valuers must be aware of this bias and use statistical measures (median, interquartile range) rather than simple averages.
Confidentiality. Many transactions are confidential. The terms that are publicly available may represent a biased sample of all transactions. The most strategically important deals — those involving the most valuable IP — are often the most closely guarded.
What Comes Next
In Lesson 7: Scenario Analysis and Sensitivity Testing, we move from single-point valuations to range-based analysis — exploring how scenario analysis and sensitivity testing strengthen any valuation by quantifying the impact of key assumptions.
Tony Hillier is an advisor to Opagio with over 30 years of experience in structured finance, valuation, and due diligence across private equity and corporate transactions. Meet the team.